The new paper reports the findings of two open-label, non-randomised phase 1/2 trials looking at a frozen formulation and a freeze-dried formulation of a two-part #COVID19 vaccine (2/8) pic.twitter.com/fcYqgpjfsl
— The Lancet (@TheLancet) September 4, 2020
The two 42-day trials also confirmed that the vaccine candidates elicit an antibody response (6/8) pic.twitter.com/dPxWT9CCrL
— The Lancet (@TheLancet) September 4, 2020
Russian officials maintain that the vaccine will be made available on an emergency basis in late October or early November. President Trump is desperately scrambling for a US vaccine alternative that can be credibly approved on an emergency basis, so he can say the same.
Meanwhile, in the US…
Johnson & Johnson says their experimental coronavirus vaccine prevented hamsters from getting severely ill. $JNJ#WakeUpWithCheddar pic.twitter.com/1N4Njy47me
— Cheddar🧀 (@cheddar) September 4, 2020
Reprinted with permission from Zero Hedge.
Undercover Epicenter N...
Buy New $24.29
(as of 02:20 UTC - Details)